NRI Named a Recipient of the 2025 NorthCoast 99 Award
NEW YORK, Aug. 25, 2025 /PRNewswire/ — NRI, a leading business and technology solutions consultancy, is proud to share that it has been named a 2025 NorthCoast... Read more.
Katie Strout Named Chief Marketing Officer at Highspring, Signaling Next Phase of Enterprise Growth
Strout played a significant role in repositioning Highspring’s consulting, managed services, and talent solutions to increase business agility for its clients. ... Read more.
B Strategy to Launch $1 Billion U.S.-Listed BNB Treasury Company with YZi Labs’ Support
The Company Aims to Become the ‘Berkshire Hathaway’ of the BNB Ecosystem. HONG KONG, Aug. 25, 2025 /PRNewswire/ — B Strategy, a leading investment... Read more.
ITF Therapeutics Announces Publication of Positive Long-Term Data Reinforcing Givinostat Efficacy and Safety as a Treatment for Duchenne Muscular Dystrophy
New data published in Annals of Clinical and Translational Neurology show that long-term treatment with givinostat can significantly delay loss of key mobility functions... Read more.
When Food Meets Tech: A Partnership Giving Canadian Kids the Power to Walk
Brar’s Donates Trexo Plus robotic walking device to Kids Physio Group, Midtown Toronto TORONTO, Aug. 25, 2025 /CNW/ – What started as a brief conversation... Read more.
Axcelis Announces Participation in Upcoming Investor Conferences in September
BEVERLY, Mass., Aug. 25, 2025 /PRNewswire/ — Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor... Read more.
Biorem Reports Second Quarter Results
GUELPH, ON, Aug. 25, 2025 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three... Read more.
Asset Entities Announces S-4 Declared Effective by SEC and Shareholder Approval Vote for Merger with Strive to be Held on September 9, 2025
DALLAS, Aug. 25, 2025 /PRNewswire/ — Asset Entities Inc. (“Asset Entities” or the “Company”) (Nasdaq: ASST), a provider of digital... Read more.
AI adoption deepens in US legal sector – 77% of orgs increased AI spend in past year and 47% call it essential to daily work, finds DeepL
New research from DeepL uncovers current and future AI trends in the legal field, including rapid adoption, the widespread use of Language AI, shifting workflows... Read more.
Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
FDA acceptance enables initiation of a Phase 2 multicenter, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of COYA 302 in patients... Read more.